tiprankstipranks
Trending News
More News >
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
US Market

Nektar Therapeutics (NKTR) Income Statement

Compare
1,563 Followers

Nektar Therapeutics Income Statement

Last quarter (Q3 2025), Nektar Therapeutics's total revenue was $11.79M, a decrease of -51.13% from the same quarter last year. In Q3, Nektar Therapeutics's net income was $-35.52M. See Nektar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 98.43M$ 90.12M$ 92.06M$ 101.91M$ 152.91M
Gross Profit
$ 67.74M$ 53.48M$ 70.42M$ 77.01M$ 133.44M
Operating Expenses
$ 172.94M$ 190.90M$ 310.66M$ 523.11M$ 513.36M
Depreciation and Amortization
$ 4.39M$ 7.82M$ 12.20M$ 14.15M$ 12.50M
EBITDA
$ -86.70M$ -243.11M$ -323.87M$ -461.82M$ -394.33M
Operating Income
$ -105.20M$ -137.43M$ -240.24M$ -446.10M$ -379.92M
Other Income/Expenses
$ -14.00M$ -138.83M$ -124.75M$ -77.18M$ -64.03M
Pretax Income
$ -119.20M$ -276.26M$ -364.98M$ -523.28M$ -443.95M
Net Income
$ -118.96M$ -276.06M$ -368.20M$ -523.84M$ -444.44M
Per Share Metrics
Basic EPS
$ -8.68$ -21.79$ -29.51$ -42.90$ -37.35
Diluted EPS
$ -8.68$ -21.79$ -29.51$ -42.90$ -37.35
Weighted Average Shares Outstanding
13.71M 12.67M 12.48M 12.22M 11.91M
Weighted Average Shares Outstanding (Diluted)
13.71M 12.67M 12.48M 12.22M 11.91M
Currency in USD

Nektar Therapeutics Earnings and Revenue History